INS and Hyperglycemia: This high prevalence of GDM recurrence can be explained by pathophysiological mechanisms: the development of GDM is closely related to subclinical impairments of insulin action and β-cell function, which eventually emerge as manifest hyperglycemia when insulin sensitivity physiologically decreases in the second and third trimester of pregnancy [1,4].